Sort   by:  
 Page size 
UnknownPatient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.
Not available
S-EPMC8257679 | biostudies-literature
UnknownAutomated harvesting and processing of protein crystals through laser photoablation.
Not available
S-EPMC4822559 | biostudies-literature
UnknownAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Not available
S-EPMC5538020 | biostudies-literature
UnknownAdjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186 | biostudies-literature
UnknownSARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
Not available
S-EPMC7995808 | biostudies-literature
UnknownOverall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Not available
S-EPMC10207856 | biostudies-literature
Sort   by:  
 Page size